Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonosis that causes death in 35·7% of cases. As of Feb 28, 2018, 2182 cases of MERS-CoV infection (with 779 deaths) in 27 countries were reported to WHO worldwide, with most being reported in Saudi Arabia (1807 cases with 705 deaths). MERS-CoV features prominently in the WHO blueprint list of priority pathogens that threaten global health security. Although primary transmission of MERS-CoV to human beings is linked to exposure to dromedary camels (Camelus dromedarius), the exact mode by which MERS-CoV infection is acquired remains undefined. Up to 50% of MERS-CoV cases in Saudi Arabia have been classified as secondary, occurring from human-to-human transmission through contact with asymptomatic or symptomatic individuals infected with MERS-CoV. Hospital outbreaks of MERS-CoV are a hallmark of MERS-CoV infection. The clinical features associated with MERS-CoV infection are not MERS-specific and are similar to other respiratory tract infections. Thus, the diagnosis of MERS can easily be missed, unless the doctor or health-care worker has a high degree of clinical awareness and the patient undergoes specific testing for MERS-CoV. The largest outbreak of MERS-CoV outside the Arabian Peninsula occurred in South Korea in May, 2015, resulting in 186 cases with 38 deaths. This outbreak was caused by a traveller with undiagnosed MERS-CoV infection who became ill after returning to Seoul from a trip to the Middle East. The traveller visited several health facilities in South Korea, transmitting the virus to many other individuals long before a diagnosis was made. With 10 million pilgrims visiting Saudi Arabia each year from 182 countries, watchful surveillance by public health systems, and a high degree of clinical awareness of the possibility of MERS-CoV infection is essential. In this Review, we provide a comprehensive update and synthesis of the latest available data on the epidemiology, determinants, and risk factors of primary, household, and nosocomial transmission of MERS-CoV, and suggest measures to reduce risk of transmission.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Figures
Comment in
-
Controversies regarding shielding and susceptibility to COVID-19 disease in liver transplant recipients in the United Kingdom.John Hann A, Lembach H, McKay SC, Perrin M, Isaac J, Oo YH, Mutimer D, Mirza DF, Hartog H, Perera T. John Hann A, et al. Transpl Infect Dis. 2020 Oct;22(5):e13352. doi: 10.1111/tid.13352. Epub 2020 Jun 17. Transpl Infect Dis. 2020. PMID: 32500939 Free PMC article. No abstract available.
References
-
- Peiris JS, Yuen KY, Osterhaus AD, Stöhr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431–2441. - PubMed
-
- WHO Severe acute respiratory syndrome. http://www.who.int/topics/sars/en/ (accessed March 28, 2018).
-
- Hui DS, Memish ZA, Zumla A. Severe acute respiratory syndrome vs the Middle East respiratory syndrome. Curr Opin Pulm Med. 2014;20:233–241. - PubMed
-
- WHO Middle East respiratory syndrome coronavirus (MERS-CoV) http://www.who.int/emergencies/mers-cov/en/ (accessed Jan 16, 2018).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
